Skip to main content
. 2020 Jan 17;98(3):skaa003. doi: 10.1093/jas/skaa003

Table 6.

Comparison of antibiotic susceptibilities between transferable copper resistance gene (tcrB)-positive and tcrB-negative Enterococcus spp. isolates from feces of piglets fed diets with or without added Cu and/or CTC1

Antimicrobial compounds Mean minimum inhibitory concentration (MIC), μg/mL2 Susceptible MIC, μg/mL Intermediate MIC, μg/mL Resistant MIC, μg/mL
tcrB-negative tcrB-positive
Chloramphenicol 32 16 ≤8 16 ≥32
Ciprofloxacin 1.1 7.7 ≤1 2 ≥4
Daptomycin 5.2 3.3 ≤4 N/A N/A3
Erythromycin 42 33.8 ≤0.5 1–4 ≥8
Gentamicin 16.8 31.6 ≤500 N/A >500
Kanamycin 102.4 115.2 ≤512 N/A ≥1,024
Lincomycin 128 37.6 ≤2 4 ≥8
Linezolid 16 52.8 ≤2 4 ≥8
Nitrofurantoin 25.6 11.2 ≤32 64 ≥128
Penicillin 1.3 2.9 ≤8 N/A ≥16
Streptomycin 102.4 78.4 ≤1,000 N/A >1,000
Synercid 5.4 5.6 ≤1 2 ≥4
Tetracycline 89.6 76.8 ≤4 8 ≥16
Tigecycline 1.95 1.2 ≤0.25 N/A N/A4
Tylosin tartrate 102.8 45.4 ≤8 16 ≥32
Vancomycin 2.9 2.7 ≤4 8–16 ≥32

1A total of 320 barrows (DNA 200 × 400, DNA Genetics, Columbus, NE) weaned at approximately 21 d of age with 7.4 kg BW were used in a 28-d nursery study. Piglets were fed a common diet during an acclimation period from days −7 to −1 and treatment diets from days 0 to 28. Treatments consisted of control, with no addition of Cu or CTC in the diet; Cu, with 200 mg/kg added Cu from copper sulfate in the diet; CTC, with 440 mg/kg CTC in the diet; and Cu + CTC, with 200 mg/kg added Cu from copper sulfate and 440 mg/kg added CTC in the diet. Dietary treatments had no effect on antimicrobial susceptibilities among enterococcal isolates (P > 0.05).

2For the purpose of averaging the transferable copper resistance gene (tcrB)-negative and tcrB-positive MIC, values that were ≥128 μg/mL were considered as 128 μg/mL.

3According to the Clinical and Laboratory Standards Institute, only a susceptible breakpoint has been established for daptomycin (≤ 4 μg/mL).

4According to the Clinical and Laboratory Standards Institute, only a susceptible breakpoint has been established for tigecycline (≤ 0.25 μg/mL).